Already a DIA Member? Sign in. Not a member? Join.

Sign in

Forgot User ID? or Forgot Password?

Not a Member?

Create Account and Join

Boston Convention and Exhibition Center

Jun 23, 2013 8:30 AM - Jun 27, 2013 12:45 PM

415 Summer Street, , Boston, MA 02210 , USA

DIA 2013 49th Annual Meeting: Advancing Therapeutic Innovation and Regulatory Science

Meeting the Operational Challenges of Risk-based Monitoring: Investigator and Sponsor Perspectives

Session Chair(s)

Donna  Dorozinsky, BSN, MSN

Donna Dorozinsky, BSN, MSN

President & CEO

Just in Time GCP, United States

Central Statistical Monitoring in Action

Learning Objective : Discuss how a well-defined quality program can assist the investigator site in preparing for risk-based monitoring; Discuss strategies for monitoring that reflect a modern, risk-based approach; Describe an understanding of the challenges and requirements of implementing Central Statistical Monitoring.

Speaker(s)

Donna  Dorozinsky, BSN, MSN

Preparing the Investigator Site for Risk-based Monitoring

Donna Dorozinsky, BSN, MSN

Just in Time GCP, United States

President & CEO

Amanda Julie Sax, RN

Risk-based Monitoring: The New Regulatory Landscape and Conjectures on the Future of Clinical Trial Execution

Amanda Julie Sax, RN

Quintiles Transnational Corp., United States

Senior Director, Integrated Processes and Technologies

Francois  Torche, MBA

Central Statistical Monitoring in Action

Francois Torche, MBA

CluePoints, Belgium

Chief Product & Technology Officer

Have an account?

Be informed and stay engaged.

Don't miss an opportunity - join our mailing list to stay up to date on DIA insights and events.